1. Home
  2. GFR vs DRTS Comparison

GFR vs DRTS Comparison

Compare GFR & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenfire Resources Ltd.

GFR

Greenfire Resources Ltd.

HOLD

Current Price

$5.94

Market Cap

713.7M

Sector

N/A

ML Signal

HOLD

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$9.69

Market Cap

641.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GFR
DRTS
Founded
2018
2015
Country
Canada
Israel
Employees
197
121
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
713.7M
641.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GFR
DRTS
Price
$5.94
$9.69
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$8.67
AVG Volume (30 Days)
245.7K
607.6K
Earning Date
05-05-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$699.98
P/E Ratio
$4.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.10
$2.81
52 Week High
$7.02
$10.80

Technical Indicators

Market Signals
Indicator
GFR
DRTS
Relative Strength Index (RSI) 46.52 64.89
Support Level $5.64 $6.59
Resistance Level $6.24 N/A
Average True Range (ATR) 0.30 0.77
MACD -0.04 0.21
Stochastic Oscillator 32.80 69.04

Price Performance

Historical Comparison
GFR
DRTS

About GFR Greenfire Resources Ltd.

Greenfire Resources Ltd explores, acquires, develops and produces oil and gas in the Canadian energy sector and internationally. Greenfire currently has two producing oil sand assets, Hangingstone Expansion and Hangingstone Demo. The company has one reportable operating segment which is made up of its oil sands operations based on geographic location : Athabasca oil sands region of Alberta, Canada, nature of the products sold and integration of facilities and operations. The company is actively developing its Hangingstone Facilities using SAGD, an enhanced oil recovery extraction method.

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

Share on Social Networks: